Lee, M.-H.M.-H.LeeLiu, K.-T.K.-T.LiuThomas, J.L.J.L.ThomasSu, Z.-L.Z.-L.SuO'Hare, D.D.O'HareVan Wuellen, T.T.Van WuellenChamarro, J.M.J.M.ChamarroBolognin, S.S.BologninLuo, S.-C.S.-C.LuoSchwamborn, J.C.J.C.SchwambornLin, H.-Y.H.-Y.LinSHYH-CHYANG LUO2021-02-042021-02-042020https://www.scopus.com/inward/record.url?eid=2-s2.0-85092417116&partnerID=40&md5=5a8869214f08cc195056de540c55b924https://scholars.lib.ntu.edu.tw/handle/123456789/546720A novel electrochemical sensor for α-synuclein, a marker for Parkinson's disease, has been developed, based on molecularly imprinted electrochemically active polymers. Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, after Alzheimer's disease. A triplication in the α-synuclein (SNCA) gene, leading to higher levels of SNCA and subsequent aggregation and neurotoxicity, is a well-described cause for the disease. Thus, the detection of SNCA levels is diagnostically important. In this work, an electrochemical method was used to optimize the synthetic self-assembly of poly(hydroxymethyl 3,4-ethylenedioxythiophene) nanotubes, using a peptide from SNCA as a template molecule, to form peptide-imprinted electrically conductive polymers on sensing electrodes. The tubular nanostructures may increase the effective sensing range. The concentration range of the SNCA peptide sensing was 0.065 pM to 0.65 nM, with a limit of detection as low as 4.0 pM. Finally, the imprinted electrode was used to detect elevated levels of SNCA in culture medium collected from human PD patient-specific midbrain organoids. Copyright ? 2020 American Chemical Society.electrochemical sensing; molecular imprinting; Parkinson's disease; poly(hydroxymethyl 3,4-ethylenedioxythiophene); α-synuclein[SDGs]SDG3Conducting polymers; Electrochemical electrodes; Electrochemical sensors; Methanol; Nanotubes; Peptides; 3 ,4-ethylenedioxythiophene; Concentration ranges; Electrically conductive polymers; ELectrochemical methods; Molecularly imprinted; Neurodegenerative disorders; Parkinson's disease; Tubular nanostructures; Neurodegenerative diseasesjournal article10.1021/acsanm.0c014762-s2.0-85092417116WOS:000566778600076